-Advertisement-
-Advertisement-
Neurology

COVID-19 vaccination doesn’t seem to increase risk of relapse in multiple sclerosis
In this systematic review and meta-analysis, researchers analyzed 19 observational studies including 14,755 patients with MS who received 23,088 doses of COVID-19 vaccines. The mean age of patients was 43.3 years with 82.6% diagnosed with relapsing-remitting MS, 12.6% with secondary-progressive MS, 6.7% with primary-progressive MS, and 2.9% with clinically isolated...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-

Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]
© 2023 MedJournal 360® is a trademark of International Healthcare Media, LLC. All rights Reserved